QRG Capital Management Inc. Makes New $273,000 Investment in Tempus AI, Inc. $TEM

Key Points

• QRG Capital Management Inc. invested approximately $273,000 in Tempus AI, Inc. by acquiring 4,293 shares during the 2nd quarter.
• Significant changes in holdings were noted, with Vanguard Group Inc. increasing its stake in Tempus AI by over 6,000% to nearly $289 million.
• Tempus AI's stock performance saw a recent rating increase from BTIG Research and Guggenheim, with target prices raised to as high as $95, indicating a positive outlook among several analysts.

QRG Capital Management Inc. acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,293 shares of the company's stock, valued at approximately $273,000.

Several other hedge funds have also modified their holdings of TEM. Vanguard Group Inc. lifted its holdings in shares of Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock valued at $289,204,000 after purchasing an additional 5,900,668 shares during the last quarter. ARK Investment Management LLC lifted its holdings in shares of Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after purchasing an additional 1,981,755 shares during the last quarter. Nikko Asset Management Americas Inc. lifted its holdings in shares of Tempus AI by 31.5% during the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock valued at $205,401,000 after purchasing an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Tempus AI by 31.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after purchasing an additional 1,016,384 shares during the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong purchased a new stake in shares of Tempus AI during the first quarter valued at $34,119,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Tempus AI

In other news, CFO James William Rogers sold 7,528 shares of Tempus AI stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $561,965.20. Following the sale, the chief financial officer owned 138,473 shares of the company's stock, valued at approximately $10,337,009.45. This trade represents a 5.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Ryan Fukushima sold 5,000 shares of Tempus AI stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $92.32, for a total value of $461,600.00. Following the sale, the chief operating officer directly owned 130,000 shares in the company, valued at $12,001,600. The trade was a 3.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 933,662 shares of company stock worth $68,070,993 in the last three months. Company insiders own 26.27% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on TEM. Weiss Ratings reissued a "sell (d-)" rating on shares of Tempus AI in a research report on Wednesday. BTIG Research upped their target price on Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research report on Wednesday, August 20th. Guggenheim upped their target price on Tempus AI from $80.00 to $95.00 and gave the stock a "buy" rating in a research report on Friday, September 26th. Bank of America upped their price target on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. Finally, HC Wainwright upped their price target on Tempus AI from $90.00 to $98.00 and gave the stock a "buy" rating in a research note on Friday, September 12th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $71.83.

Tempus AI Stock Performance

TEM opened at $96.39 on Friday. The firm has a market capitalization of $16.75 billion, a P/E ratio of -81.00 and a beta of 4.87. The stock's 50 day moving average price is $78.89 and its two-hundred day moving average price is $64.78. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $104.32.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The firm had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company's revenue was up 89.5% on a year-over-year basis. During the same quarter last year, the firm posted ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. On average, equities analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.